Exlites Holdings International, Inc. (EXHI)
0.35
-0.01
(-2.78%)
USD |
OTCM |
Aug 21, 16:00
Exlites Holdings International Profit Margin (Quarterly) : -38.74% for April 30, 2026
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| April 30, 2026 | -38.74% |
| January 31, 2026 | -104.8% |
| October 31, 2025 | -13.84% |
| July 31, 2025 | -60.81% |
| April 30, 2025 | -61.27% |
| January 31, 2025 | -5.68% |
| October 31, 2024 | -5.21% |
| July 31, 2024 | -7.84% |
| April 30, 2024 | -85.03% |
| Date | Value |
|---|---|
| October 31, 2023 | -35.34% |
| July 31, 2023 | -34.92% |
| April 30, 2023 | 33.69% |
| October 31, 2022 | -72.73% |
| July 31, 2022 | 56.41% |
| April 30, 2022 | -265.0% |
| March 31, 1999 | -8.29% |
| December 31, 1998 | -11.12% |
| September 30, 1998 | -2.38% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Xcelerate, Inc. | -- |
| Vivos Therapeutics, Inc. | -107.2% |
| Hinge Health, Inc. | 20.25% |
| Anika Therapeutics, Inc. | 10.15% |
| Enovis Corp. | -0.18% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -10.89% |
| Return on Assets | -8.86% |
| Return on Invested Capital | -10.89% |
| Operating Margin (Quarterly) | -38.74% |